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Objectives
To describe HIV testing behaviour and context of MSM in Portugal participating in the European
MSM Internet Survey (EMIS).
Methods
Data for the Portuguese sample were extracted and those for 5187 participants were analysed.
Multivariate logistic regression models were fitted to quantify the association between
participants’ characteristics and HIV testing behaviour and context.
Results
Seventy-two percent of the participants had ever been tested for HIV and among those ever
tested, 11% were diagnosed with HIV. Primary care was the most common testing setting for
HIV-negative men (37%). Compared to those never tested, men who had ever taken an HIV test
had higher educational level (aOR 1.89, 95% CI 1.67-2.14) and identified themselves as
gay/homosexual more frequently (aOR 1.94 , 95% CI 1.70-2.20). HIV testing odds significantly
increased with the number of sexual partners in the previous 12 months. Those who reported
unprotected anal intercourse (UAI) with a partner of unknown or serodiscordant HIV status in
the previous 12 months were less likely to report an HIV test (aOR 0.38, 95% CI 0.33–0.44).
Among those never tested or who tested negative, 41% and 22% reported UAI with a partner of
unknown or serodiscordant status in the previous 12 months, respectively. Among men with
diagnosed HIV, 72% were currently on antiretroviral therapy and 58% reported an undetectable
viral load. More than one third (38%) of those who had detectable or unknown/undisclosed viral
load reported at least one episode of UAI with a partner of unknown or serodiscordant HIV
status in the last 12 months.
Conclusions
Actual interventions should focus on: improving testing uptake and counselling; increasing
treatment coverage; achieving and maintaining an undetectable viral load; and intensifying
prevention efforts focused on consistent condom use.
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Introduction
The European HIV epidemic is largely concentrated in
certain sub-populations, including men who have sex with
men (MSM), migrants, injecting drug users and sex workers
[1]. Although injecting drug has been an important driver
of the HIV epidemic in Portugal, cases associated with
injection of drugs have strongly declined over the past
decade and the proportion of cases attributed to sex
between men has increased. For the 776 new cases diag-
nosed and notified in 2012 in Portugal, 63.1% (n = 490)
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were attributed to heterosexual transmission, 24.1% (n =
187) to sex between men and 10.2% (n = 79) to injecting
drug use [2].
HIV testing has been a cornerstone of AIDS prevention
strategies, as early diagnosis and treatment have both
individual and public health benefits. Most-at-risk popu-
lations have been specifically targeted, and it has been
recommend that MSM should be tested annually, or more
often depending on sexual behavior [1].
In Portugal, HIV testing is available at hospitals, primary
care centers, tuberculosis and drug treatment centres, and
private laboratories. Free anonymous HIV testing is also
available through outreach teams, and at 18 designated
testing centres, one in each health region. In addition,
Lisbon has established a community, peer-based site that
provides free anonymous counseling and testing specifi-
cally targeted at MSM.
Information about HIV testing among MSM in Portugal
is scarce. Our objective was to describe HIV testing behav-
ior and context in a large sample of MSM participating in
the European MSM Internet Survey (EMIS).
Methods
EMIS methods have been described in detail elsewhere [3].
In brief, EMIS was a joint project of academic, governmen-
tal and non-governmental partners from 38 countries in
Europe to simultaneously run an online survey in 25 dif-
ferent languages during summer 2010. EMIS was approved
by the Research Ethics Committee of the University of
Portsmouth, UK(REC application number 08/09:21).
Data for the Portuguese sample were extracted and those
for 5187 participants were analysed. Associations were
examined using odds ratios (aOR) and 95% confidence
intervals (95%CI), crude and adjusted for age, country
of birth, educational level, sexual orientation disclosure,
and UAI (unprotected anal intercourse) in the previous
12 months.
Results
The proportion of EMIS participants in Portugal tested for
HIV infection during their lifetime was 72% (n = 3723), and
65% of those without known infection had tested for HIV
in the last 12 months. Among those ever tested, 11% were
diagnosed with HIV. Among recently tested men who
remained HIV negative at the time of survey, family
doctors at National Health Service primary care centres
were the most common providers of testing (37%), followed
by community HIV testing service (19%), hospitals (17%),
private practice (15%) and blood banks while donating
blood (7%). A high proportion (90%) were satisfied with the
way the testing service maintained confidentiality and
ensured respectful treatment (92%) at their last HIV test.
However, only about half were satisfied with the counsel-
ling received and 38% reported not having received any
counselling.
Ever testing was most frequent among men aged 35–44
years and least frequent among those under 25 (83% vs.
52%, respectively; P < 0.001). However, among those ever
tested, previous year testing was most frequent in men
under 25 (77%). Compared to those who had never been
tested, men who had ever performed an HIV test had higher
educational level, identified themselves as gay/homosexual
more frequently and were out to most acquaintances
(Table 1). Also, HIV testing was more frequent among par-
ticipants living with a male partner (83% vs. 70% in those
living with a female partner and 61% in those living with
others).
Those who reported unprotected anal intercourse (UAI)
with a partner of unknown or serodiscordant HIV status in
the previous 12 months, were significantly less likely to
have ever taken an HIV test (aOR 0.38, 95% CI 0.33–0.44).
Men who had visited sex venues (aOR 2.26, 95% CI 1.94–
2.63) or had sex abroad in the previous year (aOR 2.20,
95% CI 1.90–2.56) were more likely to have ever had a test.
The odds of having taken at least one HIV test significantly
increased with the number of sexual partners in the pre-
vious 12 months: those who had had one or between two
and five partners were approximately four times more
likely to have had an HIV test than those who reported
no sexual partners in that period and the odds of being
tested increased with the number of partners (6–10 part-
ners, aOR 6.40, 95% CI 4.77–8.58; above 10 partners aOR
9.51, 95% CI 7.05–12.83). Previous testing was more com-
monly reported by men who reported the use of injection
drugs at least once during their lifetime (aOR 1.54, 95% CI
1.08–2.20).
Among those who never tested (n = 1421), about two-
thirds (41%) reported UAI with a partner of unknown
or serodiscordant status in the previous 12 months and
57% had had at least five different sexual partners in the
same period. The majority (81%) of those who had never
been tested were, however, very or quite confident that
they could get a test for HIV if they wanted to. Among men
who tested negative in their last HIV test (n = 3244), 22%
reported UAI with a partner of unknown or serodiscordant
HIV status in the previous 12 months.
About half of those who were diagnosed with HIV (total
405) knew their CD4 count at diagnosis, and of those 37%
were diagnosed late (defined as having CD4 count < 350
cells/μL). Linkage to care among men with diagnosed
HIV was high: 97% had visited a health professional in the
previous six months. Seventy-two percent were currently
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on antiretroviral therapy (ART) (after excluding 27% who
did not disclose therapy): those treated included 56% of
patients with a CD4 count > 350 cells/μL at diagnosis and
71% of late presenters. Overall, 58% reported having an
undetectable viral load. More than one third (38%) of those
infected who had detectable or unknown/undisclosed viral
load reported at least on episode of UAI with a partner
of unknown or serodiscordant HIV status in the last
12 months.
Discussion
The increased incidence of HIV in gay communities has
been documented in many other countries, and the para-
doxical increase in HIV incidence among MSM over recent
years despite increased ART coverage has been explained
by an increase in condomless sex [4,5]. In our sample of
MSM, UAI in the previous year was reported by 22% of
those who tested HIV negative and by 41% of those who
had never been tested, which means that the number of
men at risk as well as non-diagnosed HIV infections
may be substantial. There is evidence that new infections
are mainly the result of transmission from people who are
yet to be diagnosed [4], so emphasis on HIV testing is of
paramount importance.
Perception of structural barriers to testing in this sample
did not seem to be determinant, as 81% of those never
tested were confident that they could take a test. Previ-
ously, a low perceived risk of infection was the single most
important barrier (reported by 80%) to testing found in
a sample of 301 participants diagnosed between 2005
and 2008 in Portugal (18% were MSM) [6] but further
studies are needed to address this question in this specific
population.
Table 1 HIV testing uptake in MSM in Portugal according to participants’ characteristics (n = 5187): results from EMIS, 2010
Ever tested
n (%)
Never tested
n (%) OR [95% CI] aOR [95% CI]
Age (years)
<25 755 (20.3) 690 (48.6) 1 1
25–39 2067 (55.5) 532 (37.4) 3.55 [3.08-4.09] 3.28 [2.83-3.81]
≥ 40 901 (24.2) 199 (14.0) 4.14 [3.44-4.98] 4.25 [3.48-5.19]
Educational level
Low/medium 1434 (38.9) 764 (54.5) 1 1
High 2256 (61.1) 637 (45.5) 1.89 [1.67-2.14] 1.57 [1.37-1.80]
Sexual identity
Bisexual/Other 971 (26.2) 577 (40.7) 1 1
Gay/Homosexual 2741 (73.8) 840 (59.3) 1.94 [1.70-2.20] 2.02 [1.75-2.33]
Sexual orientation disclosure
Disclosure
‘Out of the closet’ 1592 (43.0) 370 (26.2) 1 1
‘In the closet’ 2114 (57.0) 1044 (73.8) 0.47 [0.41- 0.54] 0.51 [0.44 −0.59]
UAI in last 12 months
No 2791 (76.7) 826 (59.0) 1 1
Yes 847 (23.3) 574 (41.0) 0.44 [0.38-0.50] 0.38 [0.33-0.44]
Sexual partners in last 12 months
0 155 (4.2) 236 (16.8) 1 1
1 775 (21.1) 295 (21.1) 4.00 [3.18-5.10] 3.95 [3.02–5.17]
2–5 1254 (34.2) 497 (35.5) 3.84 [3.06-4.82] 4.70 [3.64-6.08]
6–10 625 (17.0) 198 (14.1) 4.81 [3.71-6.22] 6.40 [4.77-8.58]
>10 858 (23.4) 175 (12.5) 7.46 [5.76-9.68] 9.51 [7.05–12.83]
Sex abroad
No 1710 (46.4) 1020 (72.4) 1 1
Yes 1971 (53.6) 388 (27.6) 3.03 [2.65-3.46] 2.20 [1.90-2.56]
Sex venues
Never 978 (26.4) 714 (50.5) 1 1
At least once 2734 (73.6) 700 (49.5) 2.85 [2.51-3.24] 2.26 [1.94-2.63]
Syphilis history (self-reported)
No 3269 (88.5) 1376 (97.3) 1 1
Yes 425 (11.5) 38 (2.7) 4.71 [3.36-6.60] 4.42 [3.05–6.41]
Injecting drug use
Never 3480 (94.8) 1343 (96.5) 1 1
At least once 189 (5.2) 49 (3.5) 1.49 [1.08-2.05] 1.54 [1.08-2.20]
aOR: Adjusted for age, country of birth, educational level, sexual orientation disclosure and UAI in the last 12 months: unprotected anal intercourse in the
last 12 months.
aOR, adjusted odds ratio; CI, confidence interval; OR, odds ratio; UAI, unprotected anal intercourse.
HIV testing among MSM in Portugal 17
© 2013 British HIV Association HIV Medicine (2013), 14 (Suppl. 3), 15–18
Family doctors, hospitals and community HIV testing ser-
vices were the most common providers of testing, but the
proportion of MSM who used blood banks for HIV testing
was high (7%), even though the current policy in Portugal is
to screen MSM out of blood donations. As for contextual
factors associated with HIV testing, while confidentiality and
respect were considered satisfactory, counselling was consid-
ered satisfactory by only half of the participants and more
than one third did not receive any counselling at their last
test, highlighting the need to reinforce the importance of
counselling and its quality among health professionals and
social workers. We could not assess the extent to which MSM
voluntarily opted out of counselling.
HIV testing is required to ensure that infected individuals
enter clinical care and receive appropriate treatment in a
timely fashion. About three-quarters of our sample had
taken at least one HIV test during their lifetime, and 11%
were diagnosed with HIV infection. Linkage to care was
almost universal (94%) but was not completely predictive
of ART coverage or viral load undetectability.
In recent years there has been a renewed emphasis on
testing with the focus on treatment as prevention [7] but this
strategy will only work if infected people are diagnosed
earlier and indeed treated effectively. In our sample, over
one third of those infected who had detectable or unknown/
undisclosed viral load reported at least one episode of UAI
with a partner of unknown or serodiscordant HIV status in
the last 12 months. These findings stress the need to clearly
communicate that even someone on treatment might still be
infectious and thus consistent condom use should be
strongly encouraged for most MSM, even in times of broad
access to and uptake of ART.
Limitations: Although the sample was large, represent-
ing 5187 MSM in Portugal, it was non-random.
The EMIS data are likely to be biased towards those
who are better educated and internet-literate, and probably
more familiar with the gay subculture. Nonetheless, despite
the self-selection and recall biases, this is the largest
sample of MSM ever studied in Portugal.
The analysis of this large sample of MSM in Portugal
suggests that actual interventions should focus on: improv-
ing testing uptake and counselling, especially in primary
care (the most common testing setting); increasing treat-
ment coverage; achieving and maintaining an undetectable
viral load; and intensifying prevention efforts focussed on
consistent condom use.
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